Source:http://linkedlifedata.com/resource/pubmed/id/18978744
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-11-3
|
pubmed:abstractText |
Allogeneic stem cell transplant is curative for haemophagocytic lymphohistiocytosis (HLH) and refractory Langerhans cell histiocytosis (LCH). However, patients frequently have significant pre-transplant morbidity and there is high TRM. Because HLH is caused by immune dysregulation, we surmised that a reduced-intensity conditioned (RIC) regimen might be sufficient for cure, while decreasing the TRM. In 2006, we reported the outcome of 12 patients treated with RIC SCT from a matched family/unrelated or haploidentical donor. Here we discuss the update of these patients, including a total of 25 patients treated with RIC SCT for HLH and three for LCH. Twenty-one of the twenty-five patients with HLH (84%) are alive and well with remission at a median of 36 months from SCT. Mortality included pneumonitis (n=3) and hepatic rupture (n=1). All three patients treated with RIC SCT for LCH remain alive and in remission at a median of 5.1 years from SCT. Seven of twenty-four survivors (one with LCH) have mixed chimerism but remain disease-free. These data are supported by other groups including 100% survival in seven patients with HLH and 78% survival of nine patients with LCH. In summary, RIC compares favourably with conventional SCT with long-term disease control in surviving patients with both HLH and LCL, despite a significant incidence of mixed chimerism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1476-5365
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
42 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S47-50
|
pubmed:meshHeading |
pubmed-meshheading:18978744-Disease-Free Survival,
pubmed-meshheading:18978744-Histiocytosis, Langerhans-Cell,
pubmed-meshheading:18978744-Humans,
pubmed-meshheading:18978744-Liver Diseases,
pubmed-meshheading:18978744-Living Donors,
pubmed-meshheading:18978744-Lymphohistiocytosis, Hemophagocytic,
pubmed-meshheading:18978744-Pneumonia,
pubmed-meshheading:18978744-Remission Induction,
pubmed-meshheading:18978744-Rupture, Spontaneous,
pubmed-meshheading:18978744-Stem Cell Transplantation,
pubmed-meshheading:18978744-Survival Rate,
pubmed-meshheading:18978744-Transplantation, Homologous,
pubmed-meshheading:18978744-Transplantation Chimera
|
pubmed:year |
2008
|
pubmed:articleTitle |
The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis.
|
pubmed:affiliation |
Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Children NHS Trust, London, UK.
|
pubmed:publicationType |
Journal Article,
Review
|